BlueTech Research Company Snapshot

OxyMem Ltd. (Acquired by DuPont)

Acquired

Technology Offering

OxyFilm and OxyFas MABR

What is it?

Membrane aerated biofilm reactor (MABR) which uses gas-permeable membranes to deliver oxygen at a rate of 14 kgO2/kWh. This provides energy-efficient treatment while increasing treatment capacity, reducing sludge production and enhancing nitrate removal capabilities. OxyMem’s MABR is offered as a package treatment unit (OxyFilm) and for retrofits (OxyFas).

Country

Ireland

Year Founded

2013

Employees

5 to 30

Technology Business Model

Equipment / Product Sales

Company Ownership

Private

Company Investment Stage

Fully Commercial

Revenue Stage

Revenue Positive

THIS IS A PREVIEW

Only BlueTech® Research Clients have full access.

The Innovation Tracker Snap-Shot data available to subscribers provides the information necessary to make a quick assessment of the stage of a technology company in terms of key metrics such as company size, technology development stage, revenue stage, IP Position and business model.

Learn About Membership